Publication | Closed Access

Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation

Lck PhosphorylationReceptor Tyrosine KinaseT-regulatory CellImmunologyBlood CellAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyCell SignalingTumor Microenvironment